Literature DB >> 25476835

Genomic expression profiling of NK cells in health and disease.

Fuyan Wang1, Zhigang Tian, Haiming Wei.   

Abstract

NK cells are important components of innate and adaptive immunity. Functionally, they play key roles in host defense against tumors and infectious pathogens. Within the past few years, genomic-scale experiments have provided us with a plethora of gene expression data that reveal an extensive molecular and biological map underlying gene expression programs. In order to better explore and take advantage of existing datasets, we review here the genomic expression profiles of NK cells and their subpopulations in resting or stimulated states, in diseases, and in different organs; moreover, we contrast these expression data to those of other lymphocytes. We have also compiled a comprehensive list of genomic profiling studies of both human and murine NK cells in this review.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Gene expression; Genomic profiling; Microarray; Natural killer cell; Transcriptome

Mesh:

Year:  2014        PMID: 25476835     DOI: 10.1002/eji.201444998

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Activation of JAK/STAT3 restores NK-cell function and improves immune defense after brain ischemia.

Authors:  Wei-Na Jin; Andrew F Ducruet; Qiang Liu; Samuel Xiang-Yu Shi; Michael Waters; Ming Zou; Kevin N Sheth; Rayna Gonzales; Fu-Dong Shi
Journal:  FASEB J       Date:  2018-01-08       Impact factor: 5.191

Review 2.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

3.  The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing.

Authors:  Åsa K Björklund; Marianne Forkel; Simone Picelli; Viktoria Konya; Jakob Theorell; Danielle Friberg; Rickard Sandberg; Jenny Mjösberg
Journal:  Nat Immunol       Date:  2016-02-15       Impact factor: 25.606

4.  Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis.

Authors:  Isabel Ohs; Maries van den Broek; Kathrin Nussbaum; Christian Münz; Sebastian J Arnold; Sergio A Quezada; Sonia Tugues; Burkhard Becher
Journal:  Nat Commun       Date:  2016-12-16       Impact factor: 14.919

5.  Subset- and tissue-defined STAT5 thresholds control homeostasis and function of innate lymphoid cells.

Authors:  Alejandro V Villarino; Giuseppe Sciumè; Fred P Davis; Shigeru Iwata; Beatrice Zitti; Gertraud W Robinson; Lothar Hennighausen; Yuka Kanno; John J O'Shea
Journal:  J Exp Med       Date:  2017-09-15       Impact factor: 14.307

6.  Distinct Transcriptional and Alternative Splicing Signatures of Decidual CD4+ T Cells in Early Human Pregnancy.

Authors:  Weihong Zeng; Zhicui Liu; Xinmei Liu; Siming Zhang; Asma Khanniche; Ying Zheng; Xiaoling Ma; Tiantian Yu; Fuju Tian; Xiao-Rui Liu; Jianxia Fan; Yi Lin
Journal:  Front Immunol       Date:  2017-06-12       Impact factor: 7.561

7.  A long noncoding RNA positively regulates CD56 in human natural killer cells.

Authors:  Ruya Zhang; Fang Ni; Binqing Fu; Yang Wu; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  Oncotarget       Date:  2016-11-08

8.  Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures.

Authors:  May Sabry; Agnieszka Zubiak; Simon P Hood; Poppy Simmonds; Helena Arellano-Ballestero; Eily Cournoyer; Meghavi Mashar; A Graham Pockley; Mark W Lowdell
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

Review 9.  Natural Killer Cells and Thyroid Diseases.

Authors:  Eun Kyung Lee; John B Sunwoo
Journal:  Endocrinol Metab (Seoul)       Date:  2019-06

10.  Circulating CD56bright NK cells inversely correlate with survival of melanoma patients.

Authors:  Kaat de Jonge; Anna Ebering; Sina Nassiri; Hélène Maby-El Hajjami; Hajer Ouertatani-Sakouhi; Petra Baumgaertner; Daniel E Speiser
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.